- Home
- RVPH vs RMTI Comparison
RVPH vs RMTI Comparison
Compare RVPH & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- RMTI
- Stock Information
- Founded
- RVPH 2006
- RMTI 1994
- Country
- RVPH United States
- RMTI United States
- Employees
- RVPH N/A
- RMTI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- RMTI Health Care
- Exchange
- RVPH Nasdaq
- RMTI Nasdaq
- Market Cap
- RVPH 32.8M
- RMTI 32.5M
- IPO Year
- RVPH N/A
- RMTI 1998
- Fundamental
- Price
- RVPH $0.39
- RMTI $1.19
- Analyst Decision
- RVPH Strong Buy
- RMTI Strong Buy
- Analyst Count
- RVPH 5
- RMTI 2
- Target Price
- RVPH $9.00
- RMTI $4.00
- AVG Volume (30 Days)
- RVPH 3.0M
- RMTI 305.0K
- Earning Date
- RVPH 08-13-2025
- RMTI 08-07-2025
- Dividend Yield
- RVPH N/A
- RMTI N/A
- EPS Growth
- RVPH N/A
- RMTI N/A
- EPS
- RVPH N/A
- RMTI N/A
- Revenue
- RVPH N/A
- RMTI $97,727,000.00
- Revenue This Year
- RVPH N/A
- RMTI N/A
- Revenue Next Year
- RVPH N/A
- RMTI $11.16
- P/E Ratio
- RVPH N/A
- RMTI N/A
- Revenue Growth
- RVPH N/A
- RMTI 12.82
- 52 Week Low
- RVPH $0.30
- RMTI $0.78
- 52 Week High
- RVPH $4.28
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- RVPH 33.75
- RMTI 56.72
- Support Level
- RVPH $0.35
- RMTI $0.80
- Resistance Level
- RVPH $0.83
- RMTI $0.87
- Average True Range (ATR)
- RVPH 0.06
- RMTI 0.06
- MACD
- RVPH -0.02
- RMTI 0.01
- Stochastic Oscillator
- RVPH 17.98
- RMTI 94.81
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.